Stocks and Investing
Stocks and Investing
Wed, November 9, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robbie Marcus Downgraded (BVS) to Sell on, Nov 9th, 2022
Robbie Marcus of JP Morgan, Downgraded "Bioventus Inc." (BVS) to Sell on, Nov 9th, 2022.
Robbie has made no other calls on BVS in the last 4 months.
There are 2 other peers that have a rating on BVS. Out of the 2 peers that are also analyzing BVS, 1 agrees with Robbie's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $13 on, Wednesday, September 7th, 2022
This is the rating of the analyst that currently disagrees with Robbie
- Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $11 on, Tuesday, October 11th, 2022
Contributing Sources